SC
ABVX

SummitTX Capital’s Abivax ABVX Stock Holding History

SummitTX Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69M Buy
+65,216
New +$7.38M 0.22% 111
2026
Q1 		– Sell
-56,174
Closed -$7.58M – 748
2025
Q4 		$7.58M Buy
56,174
+30,354
+118% +$3.31M 0.23% 107
2025
Q3 		$2.19M Buy
+25,820
New +$1.58M 0.09% 237

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SummitTX Capital's ABVX Position: Q2 2026 in Review

SummitTX Capital opened a new position in Abivax (ABVX) in Q2 2026: 65,216 shares worth $8.69M. The stake represents 0.22% of the portfolio and ranks #111 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in ABVX as recently as Q4 2025.

SummitTX Capital first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • SummitTX Capital held 65,216 shares of Abivax worth $8.69M as of Q2 2026.
  • Abivax was a new SummitTX Capital position in Q2 2026.
  • Abivax made up 0.22% of SummitTX Capital's portfolio in Q2 2026, its #111 holding.
  • SummitTX Capital first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.